olig2 Search Results


94
Santa Cruz Biotechnology olig2
Figure 1. Generation of two distinct types of astrocytes from human glial precursors after treatment with BMP4 or CNTF. Both BMP and CNTF promote the differentiation of hGPCs into GFAP-positive astrocytes expressing S100b but with otherwise distinct morphological and antigenic phenotypes. hGDAsBMP express lower levels of GFAP and exhibit a more compact morphology. hGDAsCNTF have a more elongated morphology and expressed high levels of GFAP. hGDAsCNTF also expressed high levels of neurite-outgrowth inhibitory chondroitin sulfate proteoglycans, phosphacan and CSPG4, as well as the transcription factor <t>Olig2</t> - all of which have been found to be upregulated in glial scar
Olig2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/olig2/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
olig2 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

98
AvesLabs rabbit anti olig2
Figure 1. Generation of two distinct types of astrocytes from human glial precursors after treatment with BMP4 or CNTF. Both BMP and CNTF promote the differentiation of hGPCs into GFAP-positive astrocytes expressing S100b but with otherwise distinct morphological and antigenic phenotypes. hGDAsBMP express lower levels of GFAP and exhibit a more compact morphology. hGDAsCNTF have a more elongated morphology and expressed high levels of GFAP. hGDAsCNTF also expressed high levels of neurite-outgrowth inhibitory chondroitin sulfate proteoglycans, phosphacan and CSPG4, as well as the transcription factor <t>Olig2</t> - all of which have been found to be upregulated in glial scar
Rabbit Anti Olig2, supplied by AvesLabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti olig2/product/AvesLabs
Average 98 stars, based on 1 article reviews
rabbit anti olig2 - by Bioz Stars, 2026-04
98/100 stars
  Buy from Supplier

94
R&D Systems anti olig2
Figure 1. Generation of two distinct types of astrocytes from human glial precursors after treatment with BMP4 or CNTF. Both BMP and CNTF promote the differentiation of hGPCs into GFAP-positive astrocytes expressing S100b but with otherwise distinct morphological and antigenic phenotypes. hGDAsBMP express lower levels of GFAP and exhibit a more compact morphology. hGDAsCNTF have a more elongated morphology and expressed high levels of GFAP. hGDAsCNTF also expressed high levels of neurite-outgrowth inhibitory chondroitin sulfate proteoglycans, phosphacan and CSPG4, as well as the transcription factor <t>Olig2</t> - all of which have been found to be upregulated in glial scar
Anti Olig2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti olig2/product/R&D Systems
Average 94 stars, based on 1 article reviews
anti olig2 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
Novus Biologicals anti olig2 rabbit pab
Figure 1. Generation of two distinct types of astrocytes from human glial precursors after treatment with BMP4 or CNTF. Both BMP and CNTF promote the differentiation of hGPCs into GFAP-positive astrocytes expressing S100b but with otherwise distinct morphological and antigenic phenotypes. hGDAsBMP express lower levels of GFAP and exhibit a more compact morphology. hGDAsCNTF have a more elongated morphology and expressed high levels of GFAP. hGDAsCNTF also expressed high levels of neurite-outgrowth inhibitory chondroitin sulfate proteoglycans, phosphacan and CSPG4, as well as the transcription factor <t>Olig2</t> - all of which have been found to be upregulated in glial scar
Anti Olig2 Rabbit Pab, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti olig2 rabbit pab/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
anti olig2 rabbit pab - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

96
R&D Systems monoclonal primary antibodies against olig2
Panel A: Radial plot showing the expression of oligodendroglial markers in the two groups of DIPG, in log2 ratios related each other. The red circle represent the median expression level of the whole population of DIPG. Group 1 expresses higher levels of oligodendroglial markers than group 2 DIPG. Panel B: Morphological oligodendroglial differenciation in group 1 tumors (HES staining, ×40). Panel C: Morphological astrocytic differenciation in group 2 tumors (HES staining ×40). Panel D: <t>Olig2</t> immunohistochemistry in a group 1 DIPG showing that probably not all cells in the biopsy are tumoral (×40). Panel E: Dual immunohistochemistry for Olig2 and GFAP showing that tumor cells in mitosis are GFAP negative but Olig2 positive (×100). Panel F: Overall survival of 55 DIPG according to the presence (red) or absence (blue) of oligodendroglial differenciation. Median OS was shorter in patients with oligodendroglial type of tumors (7.73 vs 12.37, p = 0.045, log rank test).
Monoclonal Primary Antibodies Against Olig2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal primary antibodies against olig2/product/R&D Systems
Average 96 stars, based on 1 article reviews
monoclonal primary antibodies against olig2 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

96
PhosphoSolutions olig2
Panel A: Radial plot showing the expression of oligodendroglial markers in the two groups of DIPG, in log2 ratios related each other. The red circle represent the median expression level of the whole population of DIPG. Group 1 expresses higher levels of oligodendroglial markers than group 2 DIPG. Panel B: Morphological oligodendroglial differenciation in group 1 tumors (HES staining, ×40). Panel C: Morphological astrocytic differenciation in group 2 tumors (HES staining ×40). Panel D: <t>Olig2</t> immunohistochemistry in a group 1 DIPG showing that probably not all cells in the biopsy are tumoral (×40). Panel E: Dual immunohistochemistry for Olig2 and GFAP showing that tumor cells in mitosis are GFAP negative but Olig2 positive (×100). Panel F: Overall survival of 55 DIPG according to the presence (red) or absence (blue) of oligodendroglial differenciation. Median OS was shorter in patients with oligodendroglial type of tumors (7.73 vs 12.37, p = 0.045, log rank test).
Olig2, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/olig2/product/PhosphoSolutions
Average 96 stars, based on 1 article reviews
olig2 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc olig2
NSA inhibited microglia and astrocyte activation and activated oligodendrocytes in EAE mice. A - C Immunofluorescence staining was used to detect the protein expression of <t>anti-Olig2,</t> anti-Iba-1, and anti-GFAP in the lumbar spinal cords of the EAE and EAE + NSA groups. (Each Group n = 3. The data are expressed as the mean ± SEM. * P < 0.05, *** p < 0.001). D The protein expression levels of Olig2, Iba-1, and GFAP in the lumbar spinal lysate were detected by immunoblotting ( n = 6 per group). The data are expressed as the mean ± SEM. ** P < 0.01, *** p < 0.001, **** p < 0.0001)
Olig2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/olig2/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
olig2 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Neuromics mouse anti olig2
NSA inhibited microglia and astrocyte activation and activated oligodendrocytes in EAE mice. A - C Immunofluorescence staining was used to detect the protein expression of <t>anti-Olig2,</t> anti-Iba-1, and anti-GFAP in the lumbar spinal cords of the EAE and EAE + NSA groups. (Each Group n = 3. The data are expressed as the mean ± SEM. * P < 0.05, *** p < 0.001). D The protein expression levels of Olig2, Iba-1, and GFAP in the lumbar spinal lysate were detected by immunoblotting ( n = 6 per group). The data are expressed as the mean ± SEM. ** P < 0.01, *** p < 0.001, **** p < 0.0001)
Mouse Anti Olig2, supplied by Neuromics, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti olig2/product/Neuromics
Average 93 stars, based on 1 article reviews
mouse anti olig2 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
novus biologicals nbp1-28667

Nbp1 28667, supplied by novus biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nbp1-28667/product/novus biologicals
Average 94 stars, based on 1 article reviews
nbp1-28667 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
Atlas Antibodies rabbit

Rabbit, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit/product/Atlas Antibodies
Average 93 stars, based on 1 article reviews
rabbit - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology goat polyclonal anti olig2 antibody

Goat Polyclonal Anti Olig2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat polyclonal anti olig2 antibody/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
goat polyclonal anti olig2 antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


Figure 1. Generation of two distinct types of astrocytes from human glial precursors after treatment with BMP4 or CNTF. Both BMP and CNTF promote the differentiation of hGPCs into GFAP-positive astrocytes expressing S100b but with otherwise distinct morphological and antigenic phenotypes. hGDAsBMP express lower levels of GFAP and exhibit a more compact morphology. hGDAsCNTF have a more elongated morphology and expressed high levels of GFAP. hGDAsCNTF also expressed high levels of neurite-outgrowth inhibitory chondroitin sulfate proteoglycans, phosphacan and CSPG4, as well as the transcription factor Olig2 - all of which have been found to be upregulated in glial scar

Journal: PloS one

Article Title: Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury.

doi: 10.1371/journal.pone.0017328

Figure Lengend Snippet: Figure 1. Generation of two distinct types of astrocytes from human glial precursors after treatment with BMP4 or CNTF. Both BMP and CNTF promote the differentiation of hGPCs into GFAP-positive astrocytes expressing S100b but with otherwise distinct morphological and antigenic phenotypes. hGDAsBMP express lower levels of GFAP and exhibit a more compact morphology. hGDAsCNTF have a more elongated morphology and expressed high levels of GFAP. hGDAsCNTF also expressed high levels of neurite-outgrowth inhibitory chondroitin sulfate proteoglycans, phosphacan and CSPG4, as well as the transcription factor Olig2 - all of which have been found to be upregulated in glial scar

Article Snippet: Western blot analysis of chondroitin sulfate proteoglycans and Olig2 was performed as previously described [57], using anti-phosphacan monoclonal (1:1000, 3F8, Developmental Studies Hybridoma Bank), anti-CSPG4/NG2 monoclonal (1:2000, Chemicon), anti-Olig2 polyclonal (1:4000, Chemicon) and anti-b-tubulin monoclonal antibody (1:1000, Santa Cruz).

Techniques: Expressing

Panel A: Radial plot showing the expression of oligodendroglial markers in the two groups of DIPG, in log2 ratios related each other. The red circle represent the median expression level of the whole population of DIPG. Group 1 expresses higher levels of oligodendroglial markers than group 2 DIPG. Panel B: Morphological oligodendroglial differenciation in group 1 tumors (HES staining, ×40). Panel C: Morphological astrocytic differenciation in group 2 tumors (HES staining ×40). Panel D: Olig2 immunohistochemistry in a group 1 DIPG showing that probably not all cells in the biopsy are tumoral (×40). Panel E: Dual immunohistochemistry for Olig2 and GFAP showing that tumor cells in mitosis are GFAP negative but Olig2 positive (×100). Panel F: Overall survival of 55 DIPG according to the presence (red) or absence (blue) of oligodendroglial differenciation. Median OS was shorter in patients with oligodendroglial type of tumors (7.73 vs 12.37, p = 0.045, log rank test).

Journal: PLoS ONE

Article Title: Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas

doi: 10.1371/journal.pone.0030313

Figure Lengend Snippet: Panel A: Radial plot showing the expression of oligodendroglial markers in the two groups of DIPG, in log2 ratios related each other. The red circle represent the median expression level of the whole population of DIPG. Group 1 expresses higher levels of oligodendroglial markers than group 2 DIPG. Panel B: Morphological oligodendroglial differenciation in group 1 tumors (HES staining, ×40). Panel C: Morphological astrocytic differenciation in group 2 tumors (HES staining ×40). Panel D: Olig2 immunohistochemistry in a group 1 DIPG showing that probably not all cells in the biopsy are tumoral (×40). Panel E: Dual immunohistochemistry for Olig2 and GFAP showing that tumor cells in mitosis are GFAP negative but Olig2 positive (×100). Panel F: Overall survival of 55 DIPG according to the presence (red) or absence (blue) of oligodendroglial differenciation. Median OS was shorter in patients with oligodendroglial type of tumors (7.73 vs 12.37, p = 0.045, log rank test).

Article Snippet: Sections were then incubated with various commercial monoclonal primary antibodies against Olig2 (AF 2418, 1/150, R/D system, CA, USA), P53 (DO-1, 1/1, Ventana) and MIB-1 (1/100; Dako, Glostrup, Denmark).

Techniques: Expressing, Staining, Immunohistochemistry

NSA inhibited microglia and astrocyte activation and activated oligodendrocytes in EAE mice. A - C Immunofluorescence staining was used to detect the protein expression of anti-Olig2, anti-Iba-1, and anti-GFAP in the lumbar spinal cords of the EAE and EAE + NSA groups. (Each Group n = 3. The data are expressed as the mean ± SEM. * P < 0.05, *** p < 0.001). D The protein expression levels of Olig2, Iba-1, and GFAP in the lumbar spinal lysate were detected by immunoblotting ( n = 6 per group). The data are expressed as the mean ± SEM. ** P < 0.01, *** p < 0.001, **** p < 0.0001)

Journal: Inflammation

Article Title: MLKL Modulates Necroptosis and Neuroinflammation in a Mouse Model of MS

doi: 10.1007/s10753-025-02323-3

Figure Lengend Snippet: NSA inhibited microglia and astrocyte activation and activated oligodendrocytes in EAE mice. A - C Immunofluorescence staining was used to detect the protein expression of anti-Olig2, anti-Iba-1, and anti-GFAP in the lumbar spinal cords of the EAE and EAE + NSA groups. (Each Group n = 3. The data are expressed as the mean ± SEM. * P < 0.05, *** p < 0.001). D The protein expression levels of Olig2, Iba-1, and GFAP in the lumbar spinal lysate were detected by immunoblotting ( n = 6 per group). The data are expressed as the mean ± SEM. ** P < 0.01, *** p < 0.001, **** p < 0.0001)

Article Snippet: The proteins from the gel were transferred to PVDF membranes, and the membrane was blocked in rapid blocking solution for 15 min. Then incubated respectively with MLKL (Cell Signaling Technology, D2I6 N, Monoclonal, Rabbit IgG, 1:1000), RIPK3 (Cell Signaling Technology, E7 A7 F, Monoclonal, Rabbit IgG, 1:1000), P-MLKL (Affinity Biosciences, AF7420, Polyclonal, Rabbit, 1:1000), MyD88 (Abcam, ab219413, Rabbit monoclonal, 1:1000), IL-1β (ELK Biotechnology, ES3931, Polyclonal, Rabbit, 1:1000), Olig2 (Cell Signaling Technology, 65915, Monoclonal, Rabbit IgG, 1:1000), Iba-1 (Cell Signaling Technology, E404 W, Monoclonal, Rabbit IgG, 1:1000), GFAP (Cell Signaling Technology, D1 F4Q, Monoclonal, Rabbit IgG, 1:1000), NF-κB P65 (Cell Signaling Technology, D14E12, Monoclonal, Rabbit IgG, 1:1000), NLRP3 (Proteintech Group, 68102–1-Ig, Monoclonal, Mouse/IgG2a, 1:1000), GSDMD (Abcam, AB209845 , Monoclonal, Rabbit IgG, 1:1000), and caspase-1–20 (Proteinteech, 22915–1-AP, Polyclonal, Rabbit, 1:1000) antibodies overnight at 4 °C.

Techniques: Activation Assay, Immunofluorescence, Staining, Expressing, Western Blot

Journal: STAR Protocols

Article Title: Utilizing mouse optic nerve crush to examine CNS remyelination

doi: 10.1016/j.xpro.2021.100796

Figure Lengend Snippet:

Article Snippet: Rabbit anti-Olig2 (1:300) , Novus biologicals , NBP1-28667.

Techniques: Transduction, Virus, Recombinant, Sterility, Saline, Imaging, Positive Control, Software, Microscopy